Catherine Bresson

Director, Operational Team, WIN Consortium

Razelle Kurzrock

Chief, Division of Hematology & Oncology, Sr. Deputy Center Director for Clinical Science, University of California San Diego Moores Cancer Center (USA)

Vladimir Lazar

Chief Scientific and Operating Officer, WIN Consortium

Brian Leyland-Jones

Chief Medical Officer of the National Foundation of Cancer Research; Chief Scientific Officer of Darwin Foundation

Amir Onn

Head, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Richard L. Schilsky

Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology (ASCO)

Josep Tabernero

Director and Clinical Research Director, Vall d'Hebron Institute of Oncology, VHIO (Spain); ESMO President (2018 – 2019); Chair, WIN Scientific Advisory Board

Apostolia-Maria Tsimberidou

Tenured Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center (USA)

Catherine Bresson

Director, Operational Team, WIN Consortium

Layla El-Gharras

Assistant, Operational Team, WIN Consortium

Vladimir Lazar

Chief Scientific and Operating Officer, WIN Consortium

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head, WIN IT Platform

Fanny Wunder

Project Manager, WIN Consortium

Andrea Califano

Chair of Department of Systems Biology, Columbia University (USA); Vice Chairman of WIN SAB

Sung-Min Ahn

Associate Professor, Division of Oncology, Department of Internal Medicine, Gachon University Gil Medical Center (South Korea)

Phillip Febbo

Chief Medical Officer, Illumina (USA)

Robert Grossman

Faculty, Senior Fellow, Searle Chemistry Laboratory, University of Chicago (USA)

Stanley R. Hamilton

Head of Pathology & Laboratory Medicine Labs, The University of Texas, MD Anderson Cancer Center (USA)

Leroy Hood

President and Co-Founder, Institute for Systems Biology (USA)

Pasi A. Jänne

Scientific Director, Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute (USA)

Yves Luisser

Associate Vice President for Health Sciences, The University of Arizona Cancer Center (USA)

John Quackenbush

Professor, Biostatistics & Computational Biology, Dana-Farber Cancer Institute (USA)

Gideon Rechavi

Head, Sheba Cancer Research Center, Chaim Sheba Medical Center (Israel)

Gary L. Rosner

Director, Division of Biostatistics and Bioinformatics, Department of Oncology, John Hopkins Medicine (USA)

Lillian Siu

Senior Staff Physician, Division of Medical Oncology and Hematology, Princess Margaret Hospital (Canada)

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Josep Tabernero

Director and Clinical Research Director, Vall d'Hebron Institute of Oncology, VHIO (Spain); ESMO President (2018 – 2019); Chair, WIN Scientific Advisory Board

Yosef Yarden

Professor, Weizmann Institute of Science (Israel)

Gerald Batist

Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Center (Canada)

Pierre Fumoleau

General Manager, Institut Curie Hospital Group, Paris (France)

Nicolas Girard

Head of Department, Medical Oncology, Institut Curie (France)

Razelle Kurzrock

Chief, Division of Hematology & Oncology, Sr. Deputy Center Director for Clinical Science, University of California San Diego Moores Cancer Center (USA)

Ulrik Lassen

Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)

Jean-François Martini

Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)

Ni Ming

Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)

Amir Onn

Head, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Prithwish Pal

Manager, Market Development, Oncology, Illumina (USA)

Alejandro Piris

Scientific Research Manager, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Angel Porgador

Associate Professor, Ben-Gurion University of the Negev (Israel)

C.S. Pramesh

Chief, Thoracic Surgery, Division of Surgical Oncology, ACTREC - Tata Memorial Center (India)

Jacques Raynaud

President, Fondation ARC (France)

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head, WIN IT Platform

Richard L. Schilsky

Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology (ASCO)

Benjamin M. Solomon

Asst Professor of Medicine, Avera Cancer Institute (USA)

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Josep Tabernero

Director and Clinical Research Director, Vall d'Hebron Institute of Oncology, VHIO (Spain); ESMO President (2018 – 2019); Chair, WIN Scientific Advisory Board

Apostolia-Maria Tsimberidou

Tenured Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center (USA)

Casey Williams

Director of Molecular and Experimental Medicine, Avera Cancer Institute (USA)

Ding-Wei Ye

Vice President International Affairs & Professor, Chairman of Department of Urology, Fudan University Shanghai Cancer Center (China)

Luis Eduardo Rosa Zucca

Medical Oncologist, Department of Clinical Oncology - Neoplasms Sector Genitourinary, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Diana Aguirre

Senior Medical Director, Covance, Inc. (USA)

Hee Kyung Ahn

Assistant Professor, Division of Hematology and Oncology, Gachon University Gil Medical Center (South Korea)

Amal Al Omari

Director, Office of Scientific Affairs and Research, King Hussein Cancer Center (Jordan)

Gerald Batist

Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Center (Canada)

Guy Berchem

Medical Oncologist,Centre Hospitalier de Luxembourg (Luxembourg)

Raanan Berger

Director, Institute of Oncology, Sheba Medical Center (Israel)

Jean-Yves Blay

Professor of Medicine, Université Claude Bernard; Scientific Director, Canceropole Lyon Rhône Alpes, Centre Léon Bérard (France)

Rares Buiga

The Oncology Institute Ion Chiricuta (IOCN) (Romania)

David Cantú

Clinical Research, Instituto Nacional de Cancerologia (INCan)

Andrés Cervantes

Head of Section in Medical Oncology, INCLIVA (Spain)

Francesco De Lorenzo

President, European Cancer Patient Coalition - ECPC (Belgium)

Luis A. Herrera

Senior Researcher "C" of TC Definitivo of the Institute of Biomedical Research, Instituto Nacional de Cancerologia (INCan)

Susan Galbraith

Senior Vice-President IMED Oncology, AstraZeneca, Cambridge, UK

Jean Claude Gerard

VP Commercial Operations Europe, HTG Molecular (France)

Nicolas Girard

Head of Department, Medical Oncology, Institut Curie (France)

Sadakatsu Ikeda

Associate Professor, Deputy Director, Tokyo Medical and Dental University Cancer Center (Japan)

Alexandru Irimie

The University of Medicine and Pharmacy Iuliu Haţieganu (Romania)

Timothy Johnson

President and Chief Executive Officer, HTG Molecular (USA)

Masashi Kanai

Associate Professor, Department of Clinical Oncology, Pharmacogenomics and Palliative Medicine, Graduate School of Medicine, Kyoto University Hospital (Japan)

Gautam Kollu

Head of Market Development, Illumina (USA)

Razelle Kurzrock

Chief, Division of Hematology & Oncology, Sr. Deputy Center Director for Clinical Science, University of California San Diego Moores Cancer Center (USA)

Tanel Laisaar

Head of Thoracic Surgery, Department of Pulmonology and Thoracic Surgery, Lung Clinic, Tartu University Hospital (Estonia)

Catherine Larue

CEO, Luxembourg Institute of Health (Luxembourg)

Ulrik Lassen

Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)

Scott M. Lippman

Director, University of California San Diego Moores Cancer Center (USA)

Isabelle Manneh-Vangramberen

Head of Health and Research Programmes, European Cancer Patient Coalition - ECPC (Belgium)

Jean-François Martini

Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)

Giorgio Massimini

Vice President, Head Medical Officer, New Businesses;Biopharma, Global Research & Development, Merck Group KGaA (Germany)

Ni Ming

Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)

Satoshi Miyake

Director, Tokyo Medical and Dental University Cancer Center (Japan)

Manabu Muto

Professor, Department of Therapeutic Oncology, Graduate School of Medicine, Head, Department of Clinical Oncology, Kyoto University Hospital (Japan)

Ioana Berindean Neagoe

Scientific Director, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)

Hovav Nechushtan

Associate Professor, Oncology Department, Hadassah Hebrew University Medical School (Israel)

Finn Cilius Nielsen

Professor and Head, Genomic Medicine, Rigshospitalet (Denmark)

Johannes Nippgen

R&D Program Lead & Clinical Lead - Erbitux, Merck Group KGaA (China)

Amir Onn

Head, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Peeter Padrik

Director of Cancer Centre, Tartu University Hospital (Estonia)

Prithwish Pal

Manager, Market Development, Oncology, Illumina (USA)

Tamar Peretz-Yablonski

Head Department of Oncology, Hadassah Medical Center (Israel)

Thierry Philip

Chairman of the Board of Directors, Institut Curie (France)

Alejandro Piris

Scientific Research Manager, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Angel Porgador

Associate Professor, Ben-Gurion University of the Negev (Israel)

C.S. Pramesh

Chief, Thoracic Surgery, Division of Surgical Oncology, ACTREC - Tata Memorial Center (India)

Eric Raymond

Head of Medical Oncology, Groupe Hospitalier Paris Saint-Joseph (France)

Jacques Raynaud

President, Fondation ARC (France)

Rui Manuel Reis

Coordinator, Molecular Oncology Research Center, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head, WIN IT Platform

Joy Brewster Rusthoven

Executive Director (SURVIVEiT,USA)

Pierre Saintigny

Laboratory of Translational Research, Department of Translational Research and Innovation, Centre Léon Bérard (France)

Marc Schlesser

Pneumologist, Pneumology Department, Centre Hospitalier de Luxembourg (Luxembourg)

Marina Sekacheva

Head of Center for Personalized Cancer Therapy, Sechenov First Moscow State Medical University (Russia)

Manju Sengar

Medical Oncologist and Officer in charge, Clinical Research Secretariat, ACTREC - Tata Memorial Center (India)

Benjamin M. Solomon

Asst Professor of Medicine, Avera Cancer Institute (USA)

Jean-Charles Soria

Senior Vice President, Head of Oncology Innovative Medicines, MedImmune (USA)

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Andrey A. Svistunov

First Vice Rector for Innovation and International Affairs, I.M Sechenov First Moscow State Medical University (Russia)

Sun-Jin Sym

Gachon University Gil Medical Center (South Korea)

Josep Tabernero

Director and Clinical Research Director, Vall d'Hebron Institute of Oncology, VHIO (Spain); ESMO President (2018 – 2019); Chair, WIN Scientific Advisory Board

Casey Williams

Director of Molecular and Experimental Medicine, Avera Cancer Institute (USA)

Ding-Wei Ye

Vice President International Affairs & Professor, Chairman of Department of Urology, Fudan University Shanghai Cancer Center (China)

Luis Eduardo Rosa Zucca

Medical Oncologist, Department of Clinical Oncology - Neoplasms Sector Genitourinary, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)